Successful use of secukinumab in Netherton syndrome.
Publication
, Journal Article
Blanchard, SK; Prose, NS
Published in: JAAD Case Rep
June 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAAD Case Rep
DOI
ISSN
2352-5126
Publication Date
June 2020
Volume
6
Issue
6
Start / End Page
577 / 578
Location
United States
Related Subject Headings
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Blanchard, S. K., & Prose, N. S. (2020). Successful use of secukinumab in Netherton syndrome. JAAD Case Rep, 6(6), 577–578. https://doi.org/10.1016/j.jdcr.2020.04.025
Blanchard, Sarah K., and Neil S. Prose. “Successful use of secukinumab in Netherton syndrome.” JAAD Case Rep 6, no. 6 (June 2020): 577–78. https://doi.org/10.1016/j.jdcr.2020.04.025.
Blanchard SK, Prose NS. Successful use of secukinumab in Netherton syndrome. JAAD Case Rep. 2020 Jun;6(6):577–8.
Blanchard, Sarah K., and Neil S. Prose. “Successful use of secukinumab in Netherton syndrome.” JAAD Case Rep, vol. 6, no. 6, June 2020, pp. 577–78. Pubmed, doi:10.1016/j.jdcr.2020.04.025.
Blanchard SK, Prose NS. Successful use of secukinumab in Netherton syndrome. JAAD Case Rep. 2020 Jun;6(6):577–578.
Published In
JAAD Case Rep
DOI
ISSN
2352-5126
Publication Date
June 2020
Volume
6
Issue
6
Start / End Page
577 / 578
Location
United States
Related Subject Headings
- 3202 Clinical sciences